Use of leukemia inhibitory factor and endothelin antagonists
Patent Number: 6156733
Date of First Priority Issue: Monday April 24th, 1995
Date Issued: Tuesday December 5th, 2000
Assignee: Genentech, Inc. (South San Francisco, CA)
Inventors: Ferrara, Napoleone (San Francisco, CA); King, Kathleen (Pacifica, CA); Luis, Elizabeth (San Francisco, CA); Mather, Jennie P. (Millbrae, CA); Paoni, Nicholas F. (Belmont, CA)
From Class: Use
Comments: No comments
This patent teaches how to treat heart failure by administration of antagonists to endothelin and LIF.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.